Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-06

Clinical Trial Update: Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing cefepime to ceftazidime as empirical therapy for neutropenic fever has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefepime (cefepime)
  • ceftazidime (ceftazidime)

Snippet

Sponsor: Indonesia University | Conditions: Neutropenia, Febrile, Leukemia | Phase 4 | Status: COMPLETED